 |
|
|
| |
Clinical Benefits, Economic Savings and Faster Time to HCV Elimination with a Simplified
8-Week Treatment and Monitoring Program in Chronic F0-F3 Naïve Patients in the US
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Jordan Feld1, Yuri Sanchez Gonzalez2, Ana Pires Dos Santos2, Olivier Ethgen3,4
1Toronto Centre for Liver Disease, Toronto, Canada; 2AbbVie Inc., North Chicago, Illinois, United States; 3SERFAN Innovation, Namur, Belgium; 4University of Liège, Liège, Belgium
|
| |
|
|
|
|
|
